Opportunity Information: Apply for RFA PS 16 00302CONT17
This funding opportunity is a Centers for Disease Control and Prevention (CDC) cooperative agreement focused on evaluating locally developed or locally adapted "homegrown" combination HIV prevention interventions designed for transgender persons who have sex with men. In practical terms, it is aimed at supporting real-world prevention approaches that communities have already created or tailored to fit local needs, and then rigorously assessing how well those approaches work. The emphasis on "combination" prevention signals that CDC is interested in interventions that do not rely on just one tactic (for example, only counseling or only testing), but instead integrate multiple, reinforcing components that can collectively reduce HIV risk and improve prevention outcomes for the population of interest.
The opportunity is listed as a continuation announcement (Funding Opportunity Number RFA PS 16 00302CONT17), which typically indicates it is part of an ongoing program or prior funding initiative rather than a brand-new standalone solicitation. Awards are to be made through a cooperative agreement, meaning recipients should expect substantial involvement from CDC beyond what is typical for a standard grant. Cooperative agreements often include federal project officer participation in planning, technical assistance, performance monitoring, and coordination with broader CDC program goals. Applicants should plan for an interactive relationship where CDC may help shape evaluation approaches, align measures, and ensure lessons learned can be translated into broader public health practice.
The administering agency is the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), with the opportunity routed through the CDC ERA (electronic research administration) environment. The activity category is Health, and the listing is associated with CFDA number 93.084, which corresponds to CDC HIV-related prevention and surveillance assistance programs. The expected number of awards is 10, suggesting CDC anticipated funding multiple projects in different settings, likely to capture variation across local contexts and intervention models and to build a broader evidence base for what works for transgender persons who have sex with men.
Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)." That phrasing usually means eligibility is not limited strictly to one applicant type (such as only state health departments or only universities) and may include a wider set of organizations such as community-based organizations, nonprofit service providers, academic institutions, and other entities capable of implementing and evaluating interventions. In many CDC HIV prevention opportunities with similar language, emphasis is often placed on applicants with strong community connections and the ability to reach and engage priority populations in culturally responsive, affirming ways, combined with the technical capacity to conduct credible evaluation.
Key timing details in the source data include a creation date of February 24, 2017, and an original closing date of April 24, 2017. The award ceiling is listed as 0, which generally means the notice did not specify a maximum award amount in the summary fields (or that funding levels were to be determined by CDC based on available appropriations, project scope, or continuation parameters). Even when a ceiling is not provided, applicants typically must propose budgets that are reasonable, well-justified, and aligned with the intensity of the planned intervention and evaluation activities.
Overall, the core purpose of this opportunity is to strengthen HIV prevention for transgender persons who have sex with men by taking interventions that already exist in communities, or that have been adapted locally, and subjecting them to systematic evaluation. The intended outcome is not only to support service delivery, but to generate actionable evidence about effectiveness, implementation feasibility, and potential for replication or scale-up. Because this is a cooperative agreement, applicants should anticipate CDC engagement in setting evaluation standards, promoting high-quality data collection and analysis, and ensuring that results contribute to broader CDC prevention priorities and public health learning.Apply for RFA PS 16 00302CONT17
- The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Evaluating Locally-Developed or Adapted Homegrown Combination HIV Prevention Interventions for Transgender Persons who have Sex with Men" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084.
- This funding opportunity was created on Feb 24, 2017.
- Applicants must submit their applications by Apr 24, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is this funding opportunity focused on?
This opportunity is a CDC cooperative agreement to evaluate locally developed or locally adapted ("homegrown") combination HIV prevention interventions designed for transgender persons who have sex with men. The central goal is to support real-world approaches that communities have already created or tailored, and then rigorously assess how well those approaches work.
2) What does "combination HIV prevention" mean in this announcement?
"Combination" prevention means CDC is looking for interventions that integrate multiple reinforcing components, rather than relying on a single tactic. The emphasis is on a package of strategies that work together to reduce HIV risk and improve prevention outcomes for the population of interest.
3) Who is the population of interest for the interventions being evaluated?
The interventions being evaluated are designed for transgender persons who have sex with men.
4) Is this opportunity for creating a brand-new intervention or evaluating an existing one?
The opportunity is aimed at evaluating interventions that already exist locally or have been adapted locally. In practical terms, it supports community-created or community-tailored approaches and funds rigorous evaluation of their effectiveness and implementation.
5) What type of award mechanism is being used?
Awards are to be made through a cooperative agreement.
6) What is a cooperative agreement, and how is it different from a standard grant?
Under a cooperative agreement, recipients should expect substantial involvement from CDC beyond what is typical for a standard grant. This can include CDC participation through a federal project officer in planning, technical assistance, performance monitoring, coordination with CDC program goals, and collaboration to align evaluation approaches and measures.
7) What does the continuation announcement status indicate?
The listing is described as a continuation announcement (Funding Opportunity Number RFA PS 16 00302CONT17). This typically indicates the opportunity is part of an ongoing program or prior funding initiative rather than a brand-new standalone solicitation.
8) Which agency is administering this opportunity?
The administering agency is the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC).
9) What system is used to route or manage the application process?
The opportunity is routed through the CDC ERA (electronic research administration) environment.
10) What is the activity category for this opportunity?
The activity category listed is Health.
11) What is the CFDA number associated with this opportunity, and what does it relate to?
The listing is associated with CFDA number 93.084, which corresponds to CDC HIV-related prevention and surveillance assistance programs.
12) How many awards does CDC expect to make?
The expected number of awards is 10.
13) Why might CDC fund multiple awards under this opportunity?
With an expected 10 awards, CDC likely anticipated funding multiple projects in different settings to capture variation across local contexts and intervention models and to build a broader evidence base for what works for transgender persons who have sex with men.
14) Who is eligible to apply?
Eligibility is described broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)." This phrasing generally indicates eligibility is not limited to a single applicant type and may include a wider set of organizations capable of implementing and evaluating interventions.
15) What types of organizations might fit the broad eligibility description?
Based on the description provided, organizations that may be included under broad eligibility can include community-based organizations, nonprofit service providers, academic institutions, and other entities with the ability to implement and evaluate interventions.
16) What capabilities or strengths are implied as important for applicants?
The description suggests applicants may need strong community connections and the ability to reach and engage priority populations in culturally responsive, affirming ways, along with the technical capacity to conduct a credible evaluation.
17) What are the key dates listed for this opportunity?
The source data includes a creation date of February 24, 2017, and an original closing date of April 24, 2017.
18) Is there a maximum award amount (ceiling) listed?
The award ceiling is listed as 0, which generally means the notice did not specify a maximum award amount in the summary fields, or that funding levels were to be determined by CDC based on available appropriations, project scope, or continuation parameters.
19) If no award ceiling is specified, what does that imply for proposed budgets?
Even when a ceiling is not provided, applicants typically must propose budgets that are reasonable, well-justified, and aligned with the intensity of the planned intervention and evaluation activities.
20) What is CDC ultimately trying to produce through this cooperative agreement?
The core purpose is to strengthen HIV prevention for transgender persons who have sex with men by systematically evaluating locally developed or adapted interventions. The intended outcome is to generate actionable evidence about effectiveness, implementation feasibility, and potential for replication or scale-up.
21) What kinds of evaluation-related involvement should applicants expect from CDC?
Because this is a cooperative agreement, applicants should anticipate CDC engagement in setting evaluation standards, promoting high-quality data collection and analysis, aligning measures, monitoring performance, and ensuring results contribute to broader CDC prevention priorities and public health learning.
22) What is the funding opportunity number (FON) for this announcement?
The funding opportunity number is RFA PS 16 00302CONT17.
Browse more opportunities from the same category: Health
Next opportunity: Career Discovery Internship Program
Previous opportunity: Office of Innovation and Improvement (OII): Expanding Opportunity Through Quality Charter Schools Program (CSP): Grants to Charter Management Organization for the Replication and expansion of High-Quality Charter Schools CFDA Number 84.282M
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA PS 16 00302CONT17
Applicants also applied for:
Applicants who have applied for this opportunity (RFA PS 16 00302CONT17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers for Disease Control and Prevention Increase Access to Care for Black Men Who Have Sex with Men Apply for RFA PS 16 00402CONT17 Funding Number: RFA PS 16 00402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Resident Postdoctoral Fellowship Program in Microbiology Apply for CDC RFA CK12 120305CONT17 Funding Number: CDC RFA CK12 120305CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Defeat TB Apply for RFA 617 17 000004 Funding Number: RFA 617 17 000004 Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: $20,000,000 |
| Limited Competition: NIMHD Endowment Program for Increasing Research and Institutional Resources (S21) Apply for RFA MD 17 004 Funding Number: RFA MD 17 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Regional Telehealth Resource Center Program Apply for HRSA 17 015 Funding Number: HRSA 17 015 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $325,000 |
| National Telehealth Resource Center Program Apply for HRSA 17 108 Funding Number: HRSA 17 108 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $325,000 |
| Strengthening Applied Epidemiology and Sustainable International Public Health Capacity through Field Epidemiology Training Programs Apply for CDC RFA GH15 161903CONT17 Funding Number: CDC RFA GH15 161903CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| APHL-CDC Partnership to Strengthen Public Health Laboratories Internationally Apply for CDC RFA GH16 172002CONT17 Funding Number: CDC RFA GH16 172002CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH16 171802CONT17 Funding Number: CDC RFA GH16 171802CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP16 160402CONT17 Funding Number: CDC RFA IP16 160402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States” Apply for CDC RFA IP13 130405CONT17 Funding Number: CDC RFA IP13 130405CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| NIMHD Specialized Centers of Excellence for Research on Minority Health and Health Disparities (U54) Apply for RFA MD 17 005 Funding Number: RFA MD 17 005 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $950,000 |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 130605CONT17 Funding Number: CDC RFA IP13 130605CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Collaboration on Climate Sensitive Diseases and Health Effects Solicitation for FY2014 Noncompetitive Continuation Application Apply for RFA CK 14 00303CONT17 Funding Number: RFA CK 14 00303CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Enhanced Surveillance for New Vaccine Preventable Diseases Solicitation for FY2017 Apply for RFA IP16 00402CONT17 Funding Number: RFA IP16 00402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Enhanced Surveillance for New Vaccine Preventable Apply for RFA IP 16 00402CONT17 Funding Number: RFA IP 16 00402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 160302CONT17 Funding Number: CDC RFA IP16 160302CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Maintenance of Influenza Surveillance Capacity by National Health Authorities Outside the United States. Apply for CDC RFA IP16 160502CONT17 Funding Number: CDC RFA IP16 160502CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization. Apply for CDC RFA IP16 160602CONT17 Funding Number: CDC RFA IP16 160602CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization. Apply for CDC RFA IP16 160702CONT17 Funding Number: CDC RFA IP16 160702CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA PS 16 00302CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.